Search research articles
Contact Us
Filters
Showing results (71-80 of 117) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1987
Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study
Y Humblet, M Symann, A Bosly, et al.
Annals of Hematology
|
October 24, 2007
Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP
A Bosly, D Bron, A Van Hoof, et al.
European Journal of Haematology
|
September 1, 1990
High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study
P Martiat, J M Ghilain, A Ferrant, et al.
Experimental Hematology
|
September 1, 1992
Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors
A Bosly, T Guillaume, P Brice, et al.
Annals of Hematology
|
February 1, 1995
Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia
X Thomas, C Danaïla, Q K Bach, et al.
The New England Journal of Medicine
|
November 25, 1993
Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte
P Solal-Celigny, E Lepage, N Brousse, et al.
Blood
|
April 15, 1994
Interleukin-2 treatment in lymphoma: a phase II multicenter study
C Gisselbrecht, D Maraninchi, J L Pico, et al.
Bone Marrow Transplantation
|
May 1, 1995
Karyotype in acute myeloblastic leukemia: prognostic significance in a prospective study assessing bone marrow transplantation in first remission
A Ferrant, C Doyen, A Delannoy, et al.
Cancer Genetics and Cytogenetics
|
August 1, 1983
3q-, 3q+ anomaly in malignant proliferations in humans
C Mecucci, K Vermaelen, G Tricot, et al.
Bone Marrow Transplantation
|
April 28, 1999
Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?
C Jacquy, F Lambert, A Soree, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 117) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1987
Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study
Y Humblet, M Symann, A Bosly, et al.
Annals of Hematology
|
October 24, 2007
Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP
A Bosly, D Bron, A Van Hoof, et al.
European Journal of Haematology
|
September 1, 1990
High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study
P Martiat, J M Ghilain, A Ferrant, et al.
Experimental Hematology
|
September 1, 1992
Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors
A Bosly, T Guillaume, P Brice, et al.
Annals of Hematology
|
February 1, 1995
Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia
X Thomas, C Danaïla, Q K Bach, et al.
The New England Journal of Medicine
|
November 25, 1993
Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte
P Solal-Celigny, E Lepage, N Brousse, et al.
Blood
|
April 15, 1994
Interleukin-2 treatment in lymphoma: a phase II multicenter study
C Gisselbrecht, D Maraninchi, J L Pico, et al.
Bone Marrow Transplantation
|
May 1, 1995
Karyotype in acute myeloblastic leukemia: prognostic significance in a prospective study assessing bone marrow transplantation in first remission
A Ferrant, C Doyen, A Delannoy, et al.
Cancer Genetics and Cytogenetics
|
August 1, 1983
3q-, 3q+ anomaly in malignant proliferations in humans
C Mecucci, K Vermaelen, G Tricot, et al.
Bone Marrow Transplantation
|
April 28, 1999
Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?
C Jacquy, F Lambert, A Soree, et al.
Page
of 12